Home
>
National Drug Code (NDC)
>
Amoxapine
Amoxapine - 0591-5716-30 - (Amoxapine)
Drug Information of Amoxapine
| Product NDC: | 0591-5716 |
| Proprietary Name: | Amoxapine |
| Non Proprietary Name: | Amoxapine |
| Active Ingredient(s): | 150 mg/1 & nbsp; Amoxapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Amoxapine
| Product NDC: | 0591-5716 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072691 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19920828 |
Package Information of Amoxapine
| Package NDC: | 0591-5716-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (0591-5716-30) |
NDC Information of Amoxapine
| NDC Code | 0591-5716-30 |
| Proprietary Name | Amoxapine |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (0591-5716-30) |
| Product NDC | 0591-5716 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Amoxapine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19920828 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | AMOXAPINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Tricyclic Antidepressant [EPC] |
